Abstract:Classically, ATM is known for its role in sensing double-strand DNA breaks, and subsequently signaling for their repair. Non-canonical roles of ATM include transcriptional silencing, ferroptosis, autophagy and angiogenesis. Angiogenesis mediated by ATM signaling has been shown to be VEGF-independent via p38 signaling. Independently, p38 signaling has been shown to upregulate metalloproteinase expression, including MMP-2 and MMP-9, though it is unclear if this is linked to ATM. Here, we demonstrate ATM regulates aminopeptidase-N (CD13/APN/ANPEP) at the protein level. Positive correlation was seen between ATM activity and CD13 protein expression using both "wildtype" (WT) and knockout (KO) ataxia telangiectasia (AT) cells through western blotting; with the same effect shown when treating neuroblastoma cancer cell line SH-SY5Y, as well as AT-WT cells, with ATM inhibitor (ATMi; KU55933). However, qPCR along with publically available RNAseq data from Hu et al. (J. Clin. Invest., 2021, 131, e139333), demonstrated no change in mRNA levels of CD13, suggesting that ATM regulates CD13 levels via controlling protein degradation. This is further supported by the observation that incubation with proteasome inhibitors led to restoration of CD13 protein levels in cells treated with ATMi. Migration assays showed ATM and CD13 inhibition impairs migration, with no additional effect observed when combined. This suggests an epistatic effect, and that both proteins may be acting in the same signaling pathway that influences cell migration. This work indicates a novel functional interaction between ATM and CD13, suggesting ATM may negatively regulate the degradation of CD13, and subsequently cell migration.

DNA Damage Activates TGF-β Signaling Via ATM-c-Cbl-Mediated Stabilization of the Type II Receptor TβRII.

ATM-mediated KDM2A Phosphorylation is Required for the DNA Damage Repair

A Positive Role for C-Abl in Atm and Atr Activation in DNA Damage Response

ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I

Chfr and RNF8 Synergistically Regulate ATM Activation

DNA Damage-Induced Activation of ATM Promotes Β-Trcp-mediated ARID1A Ubiquitination and Destruction in Gastric Cancer Cells

The ATM-E6AP-MASTL axis mediates DNA damage checkpoint recovery

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

Buried territories: heterochromatic response to DNA double-strand breaks.

Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair

DNA Damage Response is Suppressed by the High Cyclin-dependent Kinase 1 Activity in Mitotic Mammalian Cells

ATM controls the extent of DNA end resection by eliciting sequential posttranslational modifications of CtIP

ATM and ATR：Sensing DNA Damage

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

Tip60: Connecting Chromatin to DNA Damage Signaling.

ATM Expression is Elevated in Established Radiation-Resistant Breast Cancer Cells and Improves DNA Repair Efficiency

The Atm Kinase Induces Microrna Biogenesis in the Dna Damage Response

The DNA repair kinase ATM regulates CD13 expression and cell migration

ATR/Chk1 Signaling Induces Autophagy Through Sumoylated RhoB-mediated Lysosomal Translocation of TSC2 after DNA Damage

ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage

ATM, ATR and DNA Damage-Induced Cell Cycle Arrest